Article
Pathology of the Future: Molecular Profiling for Targeted Therapy
1 Jan 2005
Abstract excerpt
Recent evidence suggests that each patient's cancer has a unique subset of molecular pathogenetic derangements. These derangements may both genetic and proteomic alterations. Genomic and proteomic research tools enable genome-wide assessment of gene expression as well as kinase driven cell signaling events. These tools are illuminating the molecular derangements of individual tumors, even if these tumors have...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
